Nevertheless, elevated ROS production in fast-proliferating neuroblastoma cells with high MYCN poses a threat to these cells when cyst(e)ine and/or selenocysteine are limiting and ferroptosis-triggering mechanisms are not suffciently counteracted. The gene discussed is MYCN; the disease is neuroblastoma.